Product List
ProductsActive Pharmaceutical Ingredients (APIs)
| No. | Product | CAS No. |
|---|---|---|
| 1 | Dantrolene Sodium | 24868-20-0 |
| 2 | Olaparib | 763113-22-0 |
| 3 | Acalabrutinib | 1420477-60-6 |
| 4 | Brigatinib | 1197953-54-0 |
| 5 | Crizotinib | 877399-52-5 |
| 6 | Eltrombopag Olamine | 496775-62-3 |
| 7 | Binimetinib | 606143-89-9 |
| 8 | Selexipag | 475086-01-2 |
| 9 | Tofacitinib Citrate | 540737-29-9 |
| 10 | Upadacitinib hemihydrate | 2050057-56-0 |
| 11 | Tasimelteon | 609799-22-6 |
| 12 | Baricitinib | 1187594-09-7 |
| 13 | Dacomitinib | 1110813-31-4 |
| 14 | Lenvatinib mesylate | 857890-39-2 |
| 15 | Erdafitinib | 1346242-81-6 |
| 16 | Sulopenem Etzadroxil | 1000296-70-7 |
| 17 | Tepotinib Hydrochloride Hydrate | 1946826-82-9 |
| 18 | Lesinurad | 878672-00-5 |
| 19 | Dabrafenib Mesylate | 1195768-06-9 |
| 20 | Capmatinib HCl hydrate | 1865733-40-9 |
| 21 | Ruxolitinib phosphate | 1092939-17-7 |
| 22 | Vandetanib | 443913-73-3 |
| 23 | Darolutamide | 1297538-32-9 |
| 24 | Gefitinib | 184475-35-2 |
| 25 | Osimertinib mesylate | 1421373-66-1 |
| 26 | Siponimod | 1230487-00-9 |
| 27 | Siponimod fumarate | 1234627-85-0 |
| 28 | Fingolimod HCl | 162359-56-0 |
| 29 | Fingolimod | 162359-55-9 |
| 30 | Tafamidis | 594839-88-0 |
| 31 | Tafamidis Meglumine | 951395-08-7 |
| 32 | Enzalutamide | 915087-33-1 |
| 33 | Lumacaftor (VX-809) | 936727-05-8 |
| 34 | Tezacaftor (VX-661) | 1152311-62-0 |
| 35 | Ivacaftor (VX-770) | 873054-44-5 |
| 36 | Elexacaftor (VX-445) | 2216712-66-0 |
| 37 | Vanzacaftor (VX-121) | 2374124-49-7 |
| 38 | Deutivacaftor (VX-561) | 1413431-07-8 |
| 39 | Rimegepant Sulfate | 1374024-48-2 |
| 40 | Diroximel Fumarate | 1577222-14-0 |
| 41 | Danuglipron | 2230198-02-2 |
| 42 | Mitotane | 53-19-0 |
| 43 | Cabozantinib Malate | 1140909-48-3 |
| 44 | Vibegron | 1190389-15-1 |
| 45 | Zavegepant HCl | 1414976-20-7 |
| 46 | Ceritinib | 1032900-25-6 |
| 47 | Fezolinetant | 1629229-37-3 |
| 48 | Elinzanetant | 929046-33-3 |
| 49 | Trametinib DMSO solvate | 1187431-43-1 |
| 50 | Vismodegib | 879085-55-9 |
| 51 | Risdiplam | 1825352-65-5 |
| 52 | Givinostat hydrochloride | 199657-29-9 |
| 53 | Givinostat hydrochloride monohydrate | 732302-99-7 |
| 54 | Avapritinib | 1703793-34-3 |
| 55 | Daraxonrasib | 2765081-21-6 |
| 56 | Lazertinib | 443797-96-4 |
| 57 | Lemborexant | 1369764-02-2 |
| 58 | Carboplatin | 41575-94-4 |
| 59 | Cisplatin | 15663-27-1 |
| 60 | Oxaliplatin | 63121-00-6 |
| 61 | Paclitaxel | 33069-62-4 |
| 62 | Docetaxel | 114977-28-5 |
| 63 | Bleomycin Sulfate | 9041-93-4 |
| 64 | Vincristine Sulphate | 2068-78-2 |
| 65 | Vinblastine Sulfate | 143-67-9 |
| 66 | Vinorelbine Tartrate | 125317-39-7 |
| 67 | Everolimus | 159351-69-6 |
| 68 | Sirolimus | 53123-88-9 |
Pharmaceutical Intermediates
Key intermediates organised by drug family. Click a name below to jump to the corresponding group.
Selexipag
Enzalutamide
Ivacaftor
Lumacaftor
Tezacaftor
Siponimod
Ozanimod
Fingolimod
Darolutamide
Apalutamide
Erlotinib
Sorafenib
Crizotinib
Sunitinib
Pazopanib
Axitinib
Lenvatinib
Tofacitinib
Abiraterone
Venetoclax
Lorlatinib
Brexpiprazole
Diroximel Fumarate
Vericiguat
Eltrombopag
Vibegron
Fezolinetant
Vismodegib
Trametinib
Elinzanetant
Dantrolene Sodium
Tovorafenib
Lazertinib
Lemborexant
Daraxonrasib
Selexipag & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Selexipag | 475086-01-2 |
| 2 | 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid | 475085-57-5 |
| 3 | 4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol | 475086-75-0 |
| 4 | 5-Chloro-2,3-diphenylpyrazine | 41270-66-0 |
| 5 | 2-Bromo-5,6-diphenylpyrazine | 243472-70-0 |
| 6 | 4-(Isopropylamino)butanol | 42042-71-7 |
Enzalutamide & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile | 143782-23-4 |
| 2 | N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | 1332524-01-2 |
| 3 | N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine | 1289942-66-0 |
Ivacaftor & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Ivacaftor (VX-770) | 873054-44-5 |
| 2 | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 13721-01-2 |
| 3 | 5-amino-2,4-di-tert-butylphenol hydrochloride | 873055-58-4 |
| 4 | 2,4-di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl methyl carbonate | 1246213-45-5 |
Lumacaftor & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Lumacaftor (VX-809) | 936727-05-8 |
| 2 | 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarbonitrile | 862574-87-6 |
| 3 | 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxylic acid | 862574-88-7 |
| 4 | 6-chloro-5-methylpyridin-2-amine | 442129-37-5 |
| 5 | 3-(6-amino-3-methylpyridin-2-yl)benzoic acid tert-butyl ester | 1083057-14-0 |
Tezacaftor & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Tezacaftor (VX-661) | 1152311-62-0 |
| 2 | 2-bromo-5-fluoro-4-nitroaniline | 952664-69-6 |
| 3 | (R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol | 14347-78-5 |
| 4 | (((2,2-dimethylbut-3-yn-1-yl)oxy)methyl)benzene | 1092536-54-3 |
| 5 | 2-[1-(benzyloxy)-2-methylpropan-2-yl]-6-fluoro-5-nitro-1H-indole | 1638771-94-4 |
Siponimod & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Siponimod | 1230487-00-9 |
| 2 | Siponimod hemi-fumarate | 1234627-85-0 |
| 3 | (E)-4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzaldehyde | 1230487-01-0 |
| 4 | O-(4-cyclohexyl-3-(trifluoromethyl)benzyl)hydroxylamine | 800379-62-8 |
| 5 | 1-(3-ethyl-4-(hydroxymethyl)phenyl)ethan-1-one | 1378888-43-7 |
Ozanimod & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Ozanimod | 1306760-87-1 |
| 2 | Ozanimod HCl | 1618636-37-5 |
| 3 | (R)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | 1306763-31-4 |
| 4 | 1-oxo-2,3-dihydro-1H-indene-4-carbonitrile | 60899-34-5 |
| 5 | Carbamic acid, N-[(1S)-2,3-dihydro-4-[(hydroxyamino)iminomethyl]-1H-inden-1-yl]-N-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-, 1,1-dimethylethyl ester | 1306763-62-1 |
| 6 | 3-cyano-4-isopropoxybenzoic acid | 258273-31-3 |
Fingolimod & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Fingolimod | 162359-55-9 |
| 2 | Fingolimod HCl | 162359-56-0 |
| 3 | N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide | 249289-10-9 |
| 4 | N-[1,1-bis[(acetyloxy)methyl]-3-phenylpropyl]acetamide | 162359-95-7 |
| 5 | 2-acetamido-2-(4-octanoylphenethyl)propane-1,3-diyl diacetate | 249289-07-4 |
| 6 | 2-acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate | 162358-09-0 |
Darolutamide & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Darolutamide | 1297538-32-9 |
| 2 | 5-acetyl-1H-pyrazole-3-carboxylic acid | 1297537-45-1 |
| 3 | (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile | 1297537-41-7 |
| 4 | 2-chloro-4-(1H-pyrazol-3-yl)benzonitrile | 1297537-37-1 |
| 5 | 5-acetyl-1(2)H-pyrazole-3-carboxylic acid ethyl ester | 37622-89-2 |
Apalutamide & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Apalutamide | 956104-40-8 |
| 2 | 5-amino-3-(trifluoromethyl)picolinonitrile | 573762-62-6 |
| 3 | 5-isothiocyanato-3-(trifluoromethyl)picolinonitrile | 951753-87-0 |
Erlotinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Erlotinib | 183321-74-6 |
| 2 | Erlotinib HCl | 183319-69-9 |
| 3 | 4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile | 236750-65-5 |
| 4 | 6,7-bis(2-methoxyethoxy)quinazolin-4(3H)-one | 179688-29-0 |
Sorafenib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Sorafenib tosylate | 475207-59-1 |
| 2 | 4-chloro-N-methylpyridine-2-carboxamide | 220000-87-3 |
| 3 | 4-chloro-3-(trifluoromethyl)phenyl isocyanate | 327-78-6 |
| 4 | 4-(4-aminophenoxy)-N-methylpicolinamide | 284462-37-9 |
Crizotinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Crizotinib | 877399-52-5 |
| 2 | 1-piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester | 877399-73-0 |
| 3 | (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | 877399-00-3 |
| 4 | tert-butyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylate | 877399-51-4 |
Sunitinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Sunitinib malate | 341031-54-7 |
| 2 | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 |
| 3 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-59-9 |
| 4 | 5-fluoro-1,3-dihydro-2H-indol-2-one | 56341-41-4 |
Pazopanib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Pazopanib HCl | 635702-64-6 |
| 2 | 2,3-dimethyl-2H-indazol-6-amine hydrochloride | 635702-60-2 |
| 3 | 3-amino-6-methylbenzenesulfonamide | 6973-09-7 |
Axitinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Axitinib | 319460-85-0 |
| 2 | 2-mercapto-N-methylbenzamide | 20054-45-9 |
| 3 | 6-iodo-1H-indazole | 261953-36-0 |
Lenvatinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Lenvatinib mesylate | 857890-39-2 |
| 2 | 1,4-dihydro-7-methoxy-4-oxo-6-quinolinecarbonitrile | 417721-15-4 |
| 3 | 4-amino-3-chlorophenol | 17609-80-2 |
Tofacitinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Tofacitinib | 477600-75-2 |
| 2 | Tofacitinib citrate | 540737-29-9 |
| 3 | (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride | 1062580-52-2 |
| 4 | 4-chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| 5 | (2,5-dioxopyrrolidin-1-yl) 2-cyanoacetate | 56657-76-2 |
Abiraterone & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Abiraterone acetate | 154229-18-2 |
| 2 | Abiraterone | 154229-19-3 |
| 3 | 17-iodoandrosta-5,16-dien-3β-ol | 32138-69-5 |
| 4 | 17-iodoandrosta-5,16-dien-3β-acetate ester | 114611-53-9 |
Venetoclax & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | 5-hydroxy-7-azaindole | 98549-88-3 |
| 2 | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate | 1235865-75-4 |
| 3 | 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine | 1228780-72-0 |
| 4 | 3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide | 1228779-96-1 |
Lorlatinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Lorlatinib | 1454846-35-5 |
| 2 | 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | 1643141-20-1 |
| 3 | 5'-fluoro-2'-iodoacetophenone | 914225-70-0 |
| 4 | (S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol | 1454847-96-1 |
| 5 | methyl (R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate | 1454848-00-0 |
Brexpiprazole & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Brexpiprazole | 913611-97-9 |
| 2 | 7-hydroxyquinolin-2(1H)-one | 70500-72-0 |
| 3 | 7-(4-chlorobutoxy)-4a,8a-dihydroquinolin-2(1H)-one | 913613-82-8 |
| 4 | 4-bromobenzo[b]thiophene | 5118-13-8 |
| 5 | 1-(benzo[b]thiophen-4-yl)piperazine hydrochloride | 913614-18-3 |
Diroximel Fumarate & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Diroximel Fumarate | 1577222-14-0 |
| 2 | 1-(2-hydroxyethyl)pyrrolidine-2,5-dione | 18190-44-8 |
Vericiguat & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Vericiguat | 1350653-20-1 |
| 2 | 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide | 1350653-27-8 |
| 3 | 2-(phenyldiazenyl)malononitrile | 6017-21-6 |
Eltrombopag & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Eltrombopag | 496775-61-2 |
| 2 | 3'-amino-2'-hydroxybiphenyl-3-carboxylic acid | 376592-93-7 |
| 3 | 3,4-dimethylphenylhydrazine hydrochloride | 86746-50-1 |
Vibegron & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Vibegron | 1190389-15-1 |
| 2 | tert-butyl (4-(3-(dimethoxyphosphoryl)-2-oxopropyl)phenyl)carbamate | 494224-44-1 |
| 3 | tert-butyl (4S,5R)-4-formyl-2,2-dimethyl-5-phenyloxazolidine-3-carboxylate | 163625-46-5 |
| 4 | (6S)-4,6,7,8-tetrahydro-4-oxo-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid | 1190392-22-3 |
| 5 | (R)-((2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol | 1295539-30-8 |
| 6 | sodium (S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate | 1421271-01-3 |
Fezolinetant & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Fezolinetant | 1629229-37-3 |
| 2 | (R)-3-methylpiperazin-2-one | 922178-61-8 |
| 3 | (R)-4-(2,4-dimethoxybenzyl)-3-methylpiperazin-2-one | 1383146-20-0 |
| 4 | 3-methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 |
Vismodegib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | 2-(2-chloro-5-nitrophenyl)pyridine | 879088-40-1 |
| 2 | 4-chloro-3-(pyridin-2-yl)aniline | 879088-41-2 |
Trametinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Trametinib | 871700-17-3 |
| 2 | Trametinib DMSO solvate | 1187431-43-1 |
| 3 | 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | 871700-22-0 |
| 4 | N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino)phenyl)acetamide | 871700-25-3 |
Elinzanetant & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Elinzanetant | 929046-33-3 |
| 2 | pyrazino[2,1-c][1,4]oxazine, octahydro-7-[(phenylmethoxy)methyl]-, (7S,9aS)-, ethanedioate (1:2) | 1268364-46-0 |
| 3 | N-[6-chloro-4-(4-fluoro-2-methylphenyl)-3-pyridinyl]-N,a,a-trimethy | 825643-73-0 |
Dantrolene Sodium & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | 5-(4-nitrophenyl)-2-furaldehyde | 7147-77-5 |
| 2 | 1-aminohydantoin hydrochloride | 2827-56-7 |
Tovorafenib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | ethyl 2-[1-[[(phenylmethoxy)carbonyl]amino]ethyl]-5-thiazolecarboxylate | 1095823-50-9 |
| 2 | 2-[1-[[(phenylmethoxy)carbonyl]amino]ethyl]-5-thiazolecarboxylic acid | 1095823-52-1 |
| 3 | 5-chloro-4-(trifluoromethyl)pyridin-2-amine | 1095823-39-4 |
Lazertinib & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Lazertinib | 443797-96-4 |
| 2 | N1-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)-6-methoxy-4-morpholinobenzene-1,3-diamine | 1903009-56-2 |
| 3 | 4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-2-pyrimidinamine | 1903009-55-1 |
| 4 | 5-chloro-4-(trifluoromethyl)pyridin-2-amine | 1903010-39-8 |
| 5 | 1-(2-chloropyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde | 1903010-38-7 |
Lemborexant & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | Lemborexant | 1369764-02-2 |
| 2 | (1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one | 528587-70-4 |
| 3 | 2,4-dimethyl-5-pyrimidinol | 412003-95-3 |
Daraxonrasib (RMC-6236) & Intermediates
| No. | Product | CAS No. |
|---|---|---|
| 1 | methyl (S)-1-((S)-3-(4-bromothiazol-2-yl)-2-((1S,2S)-2-methylcyclopropane-1-carboxamido)propanoyl)hexahydropyridazine-3-carboxylate | 3060084-27-4 |
| 2 | (S)-1-((S)-3-(4-bromothiazol-2-yl)-2-((1S,2S)-2-methylcyclopropane-1-carboxamido)propanoyl)hexahydropyridazine-3-carboxylic acid | 3060084-22-9 |
| 3 | 5-[2-((1S)-1-methoxyethyl)pyridin-3-yl]-2,2-dimethyl-5-oxopentanoic acid | 2641451-48-9 |
| 4 | (S)-3-(5-bromo-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropanoic acid | 2641451-49-0 |
| 5 | ethyl (S)-3-(5-bromo-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropanoate | 2641451-50-3 |
| 6 | 3-[5-bromo-2-[2-[(1S)-1-methoxyethyl]pyridin-3-yl]-1H-indol-3-yl]-2,2-dimethylpropan-1-ol | 3082421-34-6 |
| 7 | (S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol | 2641820-94-0 |
| 8 | (S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropyl acetate | 2865127-17-7 |
| 9 | (S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol | 3060115-68-3 |
Biological & Small Nucleic Acid Products
Biological raw materials and small nucleic acid products are one of the company's core R&D directions, covering the whole chain from research and development to industrialization.
Product list under preparation — please contact us for the latest catalogue.
Other Fine Chemicals
Fine chemicals for the cosmetics, nutraceutical and food industries, with OEM production services available.
Product list under preparation — please contact us for the latest catalogue.